Improving Tuberculosis Vaccine Trial Efficiency: A Tough Nut to Crack
- PMID: 37602513
- PMCID: PMC10629700
- DOI: 10.1093/infdis/jiad360
Improving Tuberculosis Vaccine Trial Efficiency: A Tough Nut to Crack
Comment in
-
Reply to McShane.J Infect Dis. 2024 Feb 14;229(2):616. doi: 10.1093/infdis/jiad466. J Infect Dis. 2024. PMID: 37897697 Free PMC article. No abstract available.
Comment on
-
An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine Trials.J Infect Dis. 2023 Nov 2;228(9):1150-1153. doi: 10.1093/infdis/jiad356. J Infect Dis. 2023. PMID: 37607272
References
-
- World Health Organization . Global tuberculosis report 2022. Geneva: World Health Organization, 2022.
-
- Hill PC, Cobelens F, Martinez L, et al. . An aspiration to radically shorten phase 3 tuberculosis vaccine trials . J Infect Dis. 2023; 228:1150–3. - PubMed
-
- Rodrigues LC, Pereira SM, Cunha SS, et al. . Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet 2005; 366:1290–5. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources